← FDA Drug Approvals (Drugs@FDA)

FYARRO

NDA · New Drug Application · Sponsor: AADI · Approved 2021-11-22

Drug application

FDA Application #

NDA213312

Application type

New Drug Application

Brand name

FYARRO

Generic name

SIROLIMUS

Active ingredients

SIROLIMUS

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

AADI

Manufacturer

Aadi Bioscience, Inc.

First approval

2021-11-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown